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Abstract
Background
In early 2013, a novel avian-origin influenza A(H7N9) virus emerged in China, and has
caused sporadic human infections. The incubation period is the delay from infection until
onset of symptoms, and varies from person to person. Few previous studies have examined
whether the duration of the incubation period correlates with subsequent disease severity.
Methods and Findings
We analyzed data of period of exposure on 395 human cases of laboratory-confirmed influ-
enza A(H7N9) virus infection in China in a Bayesian framework using a Weibull distribution.
We found a longer incubation period for the 173 fatal cases with a mean of 3.7 days (95%
credibility interval, CrI: 3.4–4.1), compared to a mean of 3.3 days (95% CrI: 2.9–3.6) for the
222 non-fatal cases, and the difference in means was marginally significant at 0.47 days
(95% CrI: -0.04, 0.99). There was a statistically significant correlation between a longer
incubation period and an increased risk of death after adjustment for age, sex, geographical
location and underlying medical conditions (adjusted odds ratio 1.70 per day increase in
incubation period; 95% credibility interval 1.47–1.97).
Conclusions
We found a significant association between a longer incubation period and a greater risk of
death among human H7N9 cases. The underlying biological mechanisms leading to this
association deserve further exploration.
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Introduction
The incubation period of an infectious disease, which is defined as the time between infection
and onset of symptoms, is an important biological parameter with relevance to prevention and
control of an epidemic. In early 2013, a novel avian-origin influenza A(H7N9) virus emerged
in China [1]. By 15 June 2015, 655 laboratory-confirmed cases were reported in mainland
China. The mean incubation period of human infections was around 3.4 days [2], similar to
the incubation period for human infections with influenza A(H5N1) [3], and longer than the
incubation period for human infections with seasonal influenza viruses [4].
In previous studies, we reported that fatal cases of Severe Acute Respiratory Syndrome
(SARS) coronavirus and Middle East Respiratory Syndrome (MERS) coronavirus infections
had shorter incubation periods when compared with non-fatal cases [5,6]. The relationship
between incubation period and disease severity may have a number of underlying reasons. A
greater infecting dose may be associated with a shorter incubation period and increased sever-
ity. Alternatively, underlying diseases that predispose to adverse clinical outcome may also
impact the incubation period and the subsequent disease severity. Since the pathogenesis of
some of these diseases are related to aberrant inflammatory response, the incubation period
and severity may both reflect differences in pathogenesis [7]. It has been suggested that there
are differences in the underlying pathogenesis following H7N9 virus infection compared to
influenza A(H5N1) virus and SARS or MERS coronavirus infections [8–10]. In this study we
examined the association between the severity of human infections with H7N9 virus and the
length of the incubation period.
Materials and Methods
Sources of data
All laboratory-confirmed human cases of avian influenza A(H7N9) virus infection were notified
to the Chinese Center for Disease Control and Prevention (China CDC) and relevant clinical and
epidemiological data was recorded in an electronic database [2,3]. Data extracted for this study
included age, sex, geographical location, underlying conditions and dates of illness onset and hos-
pital admission for cases reported fromMarch 2013 through August 2014. Exposure data were
available for 203/395 (51%) of cases. In the majority of those cases, the information on exposure
was recorded as intervals of 2 or more days during which infection was thought to have occurred
rather than exact dates of presumed infection [2]. For the subset of cases without available expo-
sure data, we assumed their incubation time fell in the interval (0,14) days [2].
Ethics
It was determined by the National Health and Family Planning Commission that the collection
of data from A(H7N9) cases was part of a continuing public health investigation of a notifiable
infectious disease and was exempt from institutional review board assessment. All patient rec-
ords/information was anonymized and de-identified prior to analysis.
Statistical analysis
A simple approach to estimate the incubation period distribution from interval-censored data
is to impute the midpoint of the exposure interval for each patient, and then estimate the distri-
bution based on these ‘exact’ incubation times. However, this approach is somewhat naïve, and
is likely to overestimate incubation period distributions which tend to be right-skewed [2].
Therefore to estimate the incubation period distribution, we fitted a Weibull distribution allow-
ing for interval censoring [2], estimating the shape and scale parameters using Markov Chain
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Monte Carlo in a Bayesian framework [5]. We assumed that the incubation period distribution
had different parameters among the non-fatal cases and the fatal cases and we consequently
estimated two different couple of parameters (k, θ) of the Weibull distribution using MCMC.
To evaluate the potential factors such as age, sex, location and underlying conditions that could
be associated with the length of the incubation period, we fitted to the data a multiple linear
regression model using also MCMC in a Bayesian framework with the incubation period as
response variable and age, sex, location and underlying conditions as explanatory variables.
To determine the association between the incubation period and the severity of disease, we
first estimated the difference in mean incubation period between fatal and non-fatal cases.
However this analysis could not account for potential confounders such as age that could
explain a correlation, since incubation periods can vary by age [11], and severity of H7N9
infection varies by age. We therefore specified multivariable logistic regression model where
death was the binary response variable and predictors included age, sex, geographical location,
underlying conditions and the incubation time Ti of each patient [5].
We defined a logistic regression model using incubation times resampled from the 10,000
posterior samples. This approach allowed us to simulate the distribution with imputed values
for individual incubation periods, which was particularly useful for an analysis in which we
stratified incubation periods into tertiles.
Let f and F be the pdf and cdf of the incubation period, assumed to follow a Weibull distri-
bution with parameters k and θ and stratified by clinical outcome (fatal and non-fatal cases).
Let P be the probability of death, which we assume to be dependent on age (g), sex (s), loca-
tion (l), underlying conditions (c) and incubation period (x) as in logistic regression:
P g; s; xð Þ ¼ 1
1þ exp½ðb0 þ b1g þ b2sþ b3x þ b4lnoncapital þ b5lrural þ b6cÞ
ð1Þ
For each patient with interval-censored exposure data, we estimated 10,000 posterior sam-
ples for the incubation time using MCMC and then we estimated θ = (β0, β1, β2, β3, kfc, θfc, knfc,
θnfc) simultaneously using MCMC and the following likelihood:
LðyÞ ¼
Y
i2A1
f ðxijki; yiÞ
Y
i2A2
½FðxUi jki; yiÞ  FðxLi jki; yiÞ
Y
i
qi
dið1 qiÞ1di ð2Þ
where di = 1 if case i died from the disease and 0 otherwise; (kfc, θfc) and (knfc, θnfc) are the cou-
ple of parameters of the Weibull distribution for the fatal and the non-fatal cases, respectively
and where qi = P(gi, si, xi) as deﬁned in (1).
In this analysis and the analyses described below, we specified flat priors for each parameter,
and drew 10,000 samples from the posterior distributions after a burn-in of 5,000 iterations.
Analyses were conducted using R version 3.2.2 (R Foundation for Statistical Computing,
Vienna, Austria). The raw data and R syntax allowing reproduction of the results presented in
this article are available from the Dryad Digital Repository (link to be provided in the published
version).
Results
There were 438 confirmed H7N9 cases included in the China CDC database as of the 5th
August 2014, and 43 of these were recorded as “mild” cases and were excluded from the analy-
ses here because they form only a small sample of mild H7N9 infections. Among the 395
patients included in this study who all required hospitalization for medical reasons, 173 (44%)
patients died. The mean age was 58.2 years old (±16.6 years), 71% were male, 139 (35%) cases
were residents of rural areas and 189 (68%) cases had underlying medical conditions. Fatal
H7N9 Incubation and Severity
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cases were significantly older compared to non-fatal cases (63.0 vs 54.5 years old, respectively;
p<0.001) and had a lower proportion of missing data on exposure (42% vs 54%, respectively;
p = 0.019) (Table 1).
We estimated a mean incubation period of H7N9 in all cases of 3.5 days (95% credibility
interval, CrI: 3.2–3.8) using a Weibull distribution. Moreover, no factors such as age, sex, loca-
tion and underlying conditions were significantly associated with the length of the incubation
period when fitting a multiple linear regression model (Table 2).
Table 1. Characteristics of H7N9 cases.
Patient characteristics Fatal cases Non-fatal cases Overall p-value*
All cases
Sample size, n (%) 173 (44%) 222 (56%) 395 -
Age (years); mean±SD 63.0 ± 15.5 54.5 ± 16.6 58.2 ± 16.6 <0.01
Male, n (%) 124 (72%) 156 (70%) 280 (71%) 0.85
Location, n (%) 0.87
Capital cities 48 (28%) 69 (31%) 117 (30%)
Non-capital cities 66 (38%) 73 (33%) 139 (35%)
Rural areas 59 (34%) 80 (36%) 139 (35%)
Underlying conditions1, n (%) 93 (70%) 96 (67%) 189 (68%) 0.58
Cases with recorded exposure intervals
Sample size, n (%) 101 (50%) 102 (50%) 203 -
Age (years); mean±SD 60.6 ± 15.0 55.2± 17.3 57.9 ± 16.4 0.02
Male, n (%) 72 (71%) 70 (69%) 142 (70%) 0.79
Location, n (%) 0.62
Capital cities 23 (23%) 32 (31%) 55 (27%)
Non-capital cities 40 (40%) 31 (30%) 71 (35%)
Rural areas 38 (38%) 39 (38%) 77 (38%)
Underlying conditions2, n (%) 61 (68%) 53 (65%) 114 (67%) 0.87
*p-values calculated by t-tests for age, and chi-squared tests for proportions
1 119 patients had missing data regarding this information
2 33 patients had missing data regarding this information
doi:10.1371/journal.pone.0148506.t001
Table 2. Factors associated with the incubation period.
Factors Coefﬁcient β (95% CrI)1 Coefﬁcient β (95% CrI)1
All cases Cases with recorded exposure dates
Age 0.007 (-0.003, 0.016) -0. 005 (-0.019, 0.008)
Sex (male vs female) 0.158 (-0.162, 0.488) -0.136 (-0.561, 0.293)
Location
Non-capital cities vs capital cities -0.040 (-0.422, 0.336) 0.131 (-0.404, 0.664)
Rural areas vs capital cities 0.016 (-0.358, 0.400) -0.029 (-0.554, 0.497)
Underlying conditions -0.101 (-0.530, 0.284) -0.319 (-0.212, 0.836)
1 The coefﬁcients (β) of the multiple linear regression were estimated using Markov Chain Monte Carlo
(10,000 runs) with incubation period as the outcome variable and age, sex, location and underlying
conditions as predictors. Moreover, 10,000 samples from the posterior distributions of the incubation
periods T for each patient estimated with were used here in the multiple regression model.
doi:10.1371/journal.pone.0148506.t002
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We found a longer incubation period for the 173 fatal cases with a mean of 3.7 days (95%
credibility interval, CrI: 3.4–4.1) compared with a mean of 3.3 days (95% CrI: 2.9–3.6) for the
222 non-fatal cases (Fig 1 and Fig 2), and the difference in means was marginally significant at
0.47 days (95% CrI: -0.04, 0.99). In the multivariable logistic regression model, we found that a
longer incubation period was associated with a statistically significant increased risk of death
(adjusted odds ratio, aOR = 1.70 per day increase in incubation period; 95% credibility interval,
CrI: 1.47–1.97) after adjustment for age, sex, geographical location and underlying conditions
(Table 3).
To examine the sensitivity of our results to inclusion of patients with imputed intervals for
the cases with missing exposure data, we also fitted the logistic regression models for the subset
of 203 patients with recorded exposure intervals (Table 3). We observed similar results with an
increased risk of death associated with longer incubation period (aOR = 1.57 per day increase
in incubation period; 95% CrI: 1.25–1.99). In addition, to examine the sensitivity of our results
to the assumption of a linear association between incubation time and the log-odds of death,
we categorized incubation times into tertiles and found similar results (Table 3). We also found
a similar association when stratifying by age group, with point estimates of 1.35 and 2.13 in
persons 0-59y and60y with 95% credibility intervals including the overall estimate (Table 4).
Discussion
We estimated the incubation period of H7N9 based on cases from the first two major epidemic
waves in China, and we found that fatal cases had a significantly longer incubation period than
Fig 1. Parametric estimates of the incubation period distribution for fatal (dotted line) and non-fatal cases (solid line) of laboratory-confirmed
influenza A(H7N9) virus infection. The parameters of the weibull distribution were estimated with the MCMC approach in the fatal and non-fatal cases,
respectively. The estimates are for fatal cases: k = 2.30 (95% CrI: 1.80, 2.89) and θ = 4.21 (95%CrI: 3.62, 4.85) and for non-fatal cases: k = 2.03 (95%CrI:
1.62, 2.52) and θ = 3.74 (95%CrI: 3.20, 4.36).
doi:10.1371/journal.pone.0148506.g001
H7N9 Incubation and Severity
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Fig 2. Parametric (Weibull) and nonparametric estimates (Turnbull) of the distribution of incubation
periods for human avian influenza A(H7N9) virus infections for fatal cases (above) and non-fatal
cases (below).
doi:10.1371/journal.pone.0148506.g002
H7N9 Incubation and Severity
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Table 3. Factors associated with risk of death.
Factors Risk of Death1OR
(95% CI)
Risk of Death1OR (95% CI)
Continuous incubation period using
resampling method
All patients Patients with exact
exposure dates
Incubation period2 (continuous) 1.70 (1.47–1.97) 1.57 (1.25–1.99)
Age in years 1.04 (1.02–1.05) 1.03 (1.01–1.04)
Sex (male vs female) 0.95 (0.58–1.55) 1.08 (0.56–2.24)
Location
Capital cities 1.00 1.00
Non-capital cities 1.06 (0.59–1.83) 1.52 (0.68–3.42)
Rural areas 1.02 (0.58–1.75) 1.42 (0.56–3.18)
Underlying conditions 1.03 (0.57–1.78) 1.04 (0.47–2.38)
Incubation period split into tertiles All patients Patients with exact
exposure dates
Incubation period2
- below 1st tertile (shortest)3 (reference group) 1.00 1.00
- between 1st and 2nd tertile3 3.53 (2.02–6.21) 4.80 (2.16–9.73)
- above 2nd tertile (longest)3 3.90 (2.30–7.40) 7.42 (3.34–16.25)
Age in years 1.03 (1.02–1.05) 1.03 (1.01–1.05)
Sex (male vs female) 1.03 (0.61–1.69) 1.02 (0.55–1.95)
Location
Capital cities 1.00 1.00
Non-capital cities 1.37 (0.79–2.32) 1.57 (0.71–3.66)
Rural areas 1.25 (0.75–2.16) 1.41 (0.67–3.10)
Underlying conditions 0.96 (0.55–1.67) 1.21 (0.58–2.49)
1 The coefﬁcients exp(β) of the logistic regression were estimated using Markov Chain Monte Carlo (10,000
runs) with incubation period as the outcome variable and age, sex, geographical location and underlying
conditions as predictors. Moreover, 10,000 samples from the posterior distributions of the incubation
periods T for each patient estimated with were used here in the logistic regression model.
2 10,000 samples of the incubation periods T for each patient were drawn using MCMC
3 the tertiles were 2.5 and 4.1 days for all patients and 2.5 and 4.2 days for patients with exact exposure
dates, respectively
doi:10.1371/journal.pone.0148506.t003
Table 4. Age stratified analysis of association between risk of death and estimated incubation period,
sex, location and underlying condition.
Cases Risk of Death1OR (95% CI)
0–59 years old 60 years old
All cases (n = 395) 60/1292 113/932
Incubation period1 1.35 (1.06–1.70) 2.13 (1.73–2.67)
Cases with exact exposure dates (n = 203) 41/572 60/452
Incubation period1 1.51 (1.10–2.03) 2.23 (1.49–3.43)
1 The coefﬁcients exp(β) of the logistic regression were estimated using Markov Chain Monte Carlo (10,000
runs) with incubation period as the outcome variable and age, sex, geographical location and underlying
conditions as predictors. Moreover, 10,000 samples from the posterior distributions of the incubation
periods T for each patient estimated with were used here in the logistic regression model.
2 number of fatal cases/number of non-fatal cases
doi:10.1371/journal.pone.0148506.t004
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non-fatal cases. Ours is the first study to explore the potential association between the severity
of H7N9 and the length of the incubation period.
In previous studies, we found that the length of incubation period in patients infected by
SARS and MERS coronaviruses was also significantly correlated with the severity of the disease
but in the opposite direction, with a shorter incubation period for fatal cases [5,6]. These appar-
ently conflicting results could be a consequence of the differences in the pathogenesis of H7N9
compared to the SARS and MERS coronaviruses. SARS coronavirus evade host interferon
responses but cause dysregulated pro-inflammatory cytokine responses, as also occurs in
H5N1 virus infections [8,12]. Moreover, MERS-CoV and SARS-CoV present both clinical sim-
ilarities and efficiently inhibit the activation of the type I IFN response which has not been
shown in the case of H7N9 [13–15], although other aspects of MERS-CoV pathogenesis seems
to be slightly different from SARS-CoV regarding growth characteristics, receptor usage and
host response but leading finally to more severe cytopathic effects [16–18]. Recent studies
showed that H7N9 induces a lower expression of pro-inflammatory cytokines, compared with
the “cytokine storm” induced by H5N1 virus and SARS coronavirus [9]. H7N9 viruses also dif-
fer from H5N1 virus, SARS and MERS coronaviruses in their tropism for the human upper air-
ways [18,19]. Thus H5N1 virus, SARS and MERS coronaviruses very likely have to directly
access the lower respiratory tract and alveolar epithelium to initiate infection whereas H7N9
virus can infect the upper airways. Moreover, mortality for H7N9 cases is correlated with a
wider distribution of viral antigens in the lungs [9]. Finally, human disease associated with
H7N9 virus infection differs from H5N1, SARS and MERS coronaviruses in that severe H7N9
disease is associated with exacerbation of other underlying diseases, while H5N1, SARS and
MERS coronaviruses cause disease in otherwise healthy persons. Collectively, these differences
may explain why the fatal H7N9 cases had a longer incubation period, as the virus could spread
deeper in the organism due to an abnormal immune response and potentially induced severe
adverse events, such as acute respiratory distress syndrome, increasing the risk of death [9].
Moreover, we reported in this study a mean length of H7N9 incubation period of 3.5 days
which is close to the mean incubation period estimated for H5N1 in other studies, with a mean
length of 3.3 days (95% confidence interval, CI: 2.7–3.9) [3]. Those estimates for the mean
incubation period of human infections with avian influenza viruses are longer than those
reported for human infections with seasonal influenza A viruses with a median incubation
period of 1.9 days (95% confidence interval, CI: 1.8–2.0), which could reflect differences
regarding pathogenesis between these different virus strains [20].
We also observed a significant increased risk of death among older patients. To assess the
effect of this potential cofounding factor, we applied a stratified analysis using two age groups
(0–59 years old and>60 years old) and we still observed a longer incubation period among
fatal cases, while the point estimate was larger among older patients (Table 4). However, these
two variables were not linearly correlated in this study (Table 2). This result could reflect some
potential uncontrolled cofounding effect between the length of incubation period and age,
which has been reported in previous studies [5,6,11].
Our study does have some limitations. Our estimates of the incubation period were based
on self-reported exposure data which could suffer from recall bias. We did not have data on the
frequency or intensity of exposure, which would affect the amount of virus involved in infec-
tion. Moreover, 192 patients (49%) included in our main analysis had missing data on exposure
dates, and imputation in a Bayesian framework using a wide interval of (0–14) days was neces-
sary. However, our sensitivity analysis showed that this imputation did not affect the results in
a sensitivity analysis on patients with reported exposure intervals (Table 3).
H7N9 Incubation and Severity
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In conclusion, we found a significant association between a longer incubation period and a
greater risk of death among human H7N9 cases. The underlying biological mechanisms lead-
ing to this association deserve further exploration.
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